ZOPPINI, Giacomo
 Distribuzione geografica
Continente #
NA - Nord America 11.491
EU - Europa 11.201
AS - Asia 7.119
SA - Sud America 1.065
Continente sconosciuto - Info sul continente non disponibili 383
AF - Africa 172
OC - Oceania 24
AN - Antartide 1
Totale 31.456
Nazione #
US - Stati Uniti d'America 11.325
GB - Regno Unito 3.757
RU - Federazione Russa 3.321
SG - Singapore 2.806
CN - Cina 2.135
IT - Italia 1.118
BR - Brasile 831
HK - Hong Kong 628
VN - Vietnam 624
FR - Francia 569
SE - Svezia 506
DE - Germania 504
IE - Irlanda 475
FI - Finlandia 460
KR - Corea 266
UA - Ucraina 189
BD - Bangladesh 136
IN - India 100
AR - Argentina 78
CA - Canada 76
ID - Indonesia 69
NL - Olanda 65
JP - Giappone 61
TR - Turchia 50
IQ - Iraq 44
EC - Ecuador 42
ZA - Sudafrica 42
MX - Messico 41
PL - Polonia 38
CO - Colombia 37
ES - Italia 36
NG - Nigeria 33
BE - Belgio 32
SA - Arabia Saudita 30
PK - Pakistan 28
AU - Australia 22
EG - Egitto 22
CL - Cile 19
AT - Austria 18
VE - Venezuela 16
IR - Iran 15
IL - Israele 14
JO - Giordania 14
KE - Kenya 14
RO - Romania 14
BO - Bolivia 13
MY - Malesia 13
JM - Giamaica 12
MA - Marocco 12
PY - Paraguay 12
UZ - Uzbekistan 12
AZ - Azerbaigian 11
LT - Lituania 11
PE - Perù 11
AE - Emirati Arabi Uniti 10
CH - Svizzera 9
TN - Tunisia 9
DK - Danimarca 8
ET - Etiopia 8
EU - Europa 8
GR - Grecia 8
PH - Filippine 8
AL - Albania 7
CR - Costa Rica 7
KG - Kirghizistan 7
BG - Bulgaria 6
CZ - Repubblica Ceca 6
DZ - Algeria 6
HU - Ungheria 6
XK - ???statistics.table.value.countryCode.XK??? 6
HN - Honduras 5
KZ - Kazakistan 5
LV - Lettonia 5
AM - Armenia 4
BY - Bielorussia 4
DO - Repubblica Dominicana 4
MD - Moldavia 4
PR - Porto Rico 4
PS - Palestinian Territory 4
PT - Portogallo 4
TT - Trinidad e Tobago 4
TW - Taiwan 4
UY - Uruguay 4
BA - Bosnia-Erzegovina 3
CI - Costa d'Avorio 3
GT - Guatemala 3
HR - Croazia 3
MK - Macedonia 3
NO - Norvegia 3
OM - Oman 3
RS - Serbia 3
SK - Slovacchia (Repubblica Slovacca) 3
TG - Togo 3
BH - Bahrain 2
BJ - Benin 2
CY - Cipro 2
GH - Ghana 2
LA - Repubblica Popolare Democratica del Laos 2
LC - Santa Lucia 2
LU - Lussemburgo 2
Totale 31.045
Città #
Southend 3.471
Singapore 1.452
Jacksonville 1.301
Chandler 1.132
Ashburn 1.118
Moscow 1.048
San Jose 923
Dallas 827
Woodbridge 757
Hong Kong 618
Ann Arbor 581
Dublin 471
Houston 442
Council Bluffs 399
Verona 374
Beijing 338
The Dalles 292
Wilmington 218
Ho Chi Minh City 217
Lawrence 207
Princeton 207
Jinan 198
New York 188
Los Angeles 162
Nanjing 159
Shenyang 127
Hanoi 110
Milan 110
Buffalo 108
Hebei 89
Helsinki 88
Sindelfingen 86
Santa Clara 78
Munich 77
Tianjin 74
Columbus 73
São Paulo 71
Lancaster 64
Zhengzhou 59
Changsha 57
Seoul 56
Orem 54
Jiaxing 53
Tokyo 53
Redondo Beach 52
Haikou 51
Nanchang 51
Dong Ket 46
San Francisco 43
Taizhou 43
Guangzhou 42
Hangzhou 42
Ningbo 41
Jakarta 39
Phoenix 37
Taiyuan 37
Redmond 35
Turku 35
Boardman 32
Chicago 32
Abuja 31
Atlanta 31
Warsaw 31
Brussels 30
Da Nang 30
Frankfurt am Main 30
Rio de Janeiro 29
Rome 29
Bologna 28
Redwood City 27
Seattle 27
Naples 26
Chennai 25
Kent 25
Norwalk 25
Belo Horizonte 24
Brooklyn 24
Johannesburg 24
Montreal 24
Toronto 24
Denver 23
Haiphong 21
Washington 21
London 19
Turin 19
Boston 18
Brasília 18
Falls Church 18
Guayaquil 18
Lahore 18
Amsterdam 17
Düsseldorf 17
Fairfield 17
Lanzhou 17
Stockholm 17
Poplar 15
Cairo 14
Curitiba 14
Hải Dương 14
Romola 14
Totale 20.138
Nome #
Mitral Regurgitation and Increased Risk of All-Cause and Cardiovascular Mortality in Patients with Type 2 Diabetes 650
Mortality from chronic liver diseases in diabetes 605
Validation of the Italian version of the WHO-Well-Being Questionnaire (WHO-WBQ) and the WHO-Diabetes Treatment Satisfaction Questionnaire (WHO-DTSQ). 553
Severe hypoglycemia in patients with known diabetes requiring emergency department care: a report from an Italian multicenter study. 395
Heart valve calcification in patients with type 2 diabetes and nonalcoholic fatty liver disease. 265
Long-Acting GLP-1 Receptor Agonist Exenatide Influence on the Autonomic Cardiac Sympatho-Vagal Balance 254
Both resistance training and aerobic training reduce hepatic fat content in type 2 diabetic subjects with NAFLD (The RAED2 randomized trial). 252
Glycated haemoglobin is inversely related to serum vitamin d levels in type 2 diabetic patients. 238
Aortic and mitral annular calcification are predictive of all-cause and cardiovascular mortality in patients with type 2 diabetes. 234
A renal genetic risk score (GRS) is associated with kidney dysfunction in people with type 2 diabetes 232
Abnormal serum alanine aminotransferase levels are associated with impaired insulin sensitivity in young women with polycystic ovary syndrome. 225
Association between plasma triglycerides and HDL-cholesterol and microvascular kidney disease and retinopathy in type 2 diabetes: a global case-control study in 13 countries. 213
Nonalcoholic Fatty Liver Disease Is Independently Associated With an Increased Incidence of Chronic Kidney Disease in Patients With Type 1 Diabetes. 212
Association between subclinical left ventricular systolic dysfunction and glycemic control in asymptomatic type 2 diabetic patients with preserved left ventricular function 211
Increased aortic stiffness index in patients with type 1 diabetes without cardiovascular disease compared to controls 209
Association between non-alcoholic fatty liver disease and bone turnover biomarkers in post-menopausal women with type 2 diabetes 208
Non-alcoholic fatty liver disease is associated with an increased prevalence of atrial fibrillation in hospitalized patients with type 2 diabetes. 207
Association of nonalcoholic fatty liver disease with QTc interval in patients with type 2 diabetes. 203
Antidromic sensory nerve conduction study of the digital branches of the medial plantar nerve: A novel method to detect early diabetic sensory axonal polyneuropathy. 203
Association between decreasing estimated glomerular filtration rate and risk of cardiac conduction defects in patients with type 2 diabetes 202
Nonalcoholic fatty liver disease is associated with an increased prevalence of distal symmetric polyneuropathy in adult patients with type 1 diabetes 201
Metabolic effects of aerobic training and resistance training in type 2 diabetic subjects: a randomized controlled trial (the RAED2 study). 197
Lower levels of 25-hydroxyvitamin D3 are associated with a higher prevalence of microvascular complications in patients with type 2 diabetes. 197
Chronic complications in patients with newly diagnosed type 2 diabetes: prevalence and related metabolic and clinical features: the Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 9 197
Association between non-alcoholic fatty liver disease and decreased lung function in adults: a systematic review and meta-analysis 195
Clinical factors that predict remission of diabetes after different bariatric surgical procedures: interdisciplinary group of bariatric surgery of Verona (G.I.C.O.V.) 195
Prevalence of Cardiovascular Autonomic Neuropathy in a Cohort of Patients With Newly Diagnosed Type 2 Diabetes: The Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 194
Nonalcoholic Fatty Liver Disease Is Independently Associated with Early Left Ventricular Diastolic Dysfunction in Patients with Type 2 Diabetes 193
Non-alcoholic fatty liver disease and increased risk of all-cause mortality in elderly patients admitted for acute heart failure 193
Association between serum TSH, free T4 and serum liver enzyme activities in a large cohort of unselected outpatients. 191
Nonalcoholic Fatty Liver Disease Is Associated With Ventricular Arrhythmias in Patients With Type 2 Diabetes Referred for Clinically Indicated 24-Hour Holter Monitoring 189
Non-alcoholic fatty liver disease is associated with an increased incidence of atrial fibrillation in patients with type 2 diabetes. 186
Serum uric acid levels and incident chronic kidney disease in patients with type 2 diabetes and preserved kidney function 185
Comparison of two creatinine-based estimating equations in predicting all-cause and cardiovascular mortality in patients with type 2 diabetes. 185
Prevalence of neuropathy in type 2 diabetic patients and its association with other diabetes complications: The Verona Diabetic Foot Screening Program. 185
Hyperuricemia is associated with an increased prevalence of paroxysmal atrial fibrillation in patients with type 2 diabetes referred for clinically indicated 24-h Holter monitoring 183
Hyperuricemia is associated with an increased prevalence of atrial fibrillation in hospitalized patients with type 2 diabetes 181
Hemostatic and fibrinolytic abnormalities in endocrine diseases: a narrative review. [Review] 181
Confronto degli effetti metabolici dell'esercizio aerobico e dell'esercizio di forza nel diabete tipo 2 180
Anaemia, independent of chronic kidney disease, predicts all-cause and cardiovascular mortality in type 2 diabetic patients. 179
Enzimi nel metabolismo glucidico nell'obesità e nel diabete. 178
Antiphosphotyrosine antibodies: preparation and applications 178
Relation of serum gamma-glutamyltransferase to atherogenic dyslipidemia and glycemic control in type 2 diabetes. 178
Relationship between increased left atrial volume and microvascular complications in patients with type 2 diabetes 178
Short-term and long-term risk factors in gastric cancer 178
Nonalcoholic fatty liver disease is associated with an increased risk of heart block in hospitalized patients with type 2 diabetes mellitus 178
Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial 177
Diabetic retinopathy is associated with an increased incidence of cardiovascular events in type 2 diabetic patients. 177
Type 2 diabetes is associated with an increased prevalence of respiratory symptoms as compared to the general population 176
Predictors of estimated glomerular filtration rate decline in patients with type 2 diabetes and preserved kidney function. 174
Association between non-alcoholic fatty liver disease and risk of atrial fibrillation in adult individuals: An updated meta-analysis 172
Livelli plasmatici di C-peptide e glucagone in soggetti obesi durante clamp iperglicemico con e senza infusione di somatostatina. 171
Elevated serum uric acid concentrations independently predict cardiovascular mortality in type 2 diabetic patients. 171
Increased prevalence of chronic kidney disease in patients with type 1 diabetes and non-alcoholic fatty liver. 171
Cause-specific mortality in type 2 diabetes mellitus. The Verona Diabetes Study 170
IL TRASPORTO DEL GLUCOSIO ED IL CONTROLLO FARMACOLOGICO DEL METABOLISMO GLUCIDICO 169
Nonalcoholic Fatty Liver Disease Is Associated With Higher 1-year All-Cause Rehospitalization Rates in Patients Admitted for Acute Heart Failure 167
Association between nonalcoholic fatty liver disease and colorectal Tumours in asymptomatic adults undergoing screening colonoscopy: a systematic review and meta-analysis 167
Usefulness of Subclinical Left Ventricular Midwall Dysfunction to Predict Cardiovascular Mortality in Patients With Type 2 Diabetes Mellitus. 166
Impaired Aortic Valve Growth in Type 1 Diabetes Mellitus 165
Phosphotyrosine protein profiles in monocytes stimulated by insulin and IGF-1 163
Evidence of left atrial remodeling and left ventricular diastolic dysfunction in type 2 diabetes mellitus with preserved systolic function 160
Left ventricular chamber dilation and filling pressure may help to categorise patients with type 2 diabetes 159
Growth hormone response to insulin in type 1 diabetics with and without retinopathy. 158
Antiretroviral therapy-associated diseases are common in the long-term 158
Estimated peak systolic pulmonary artery pressure in young non-complicated patients with type 1 diabetes 158
Glomerular filtration rate decline in T2DM following diagnosis. The Verona newly diagnosed diabetes study-12 158
Glucose transport and pharmacological control of glucose metabolism. 157
Increased prevalence of cardiovascular disease in type 1 diabetic patients with non-alcoholic fatty liver disease. 157
Relation of elevated serum uric acid levels to first-degree heart block and other cardiac conduction defects in hospitalized patients with type 2 diabetes 157
Association Between Nonalcoholic Fatty Liver Disease and Reduced Bone Mineral Density in Children: A Meta-Analysis 157
Higher HDL cholesterol levels are associated with a lower incidence of chronic kidney disease in patients with type 2 diabetes 155
Association Between Primary Hypothyroidism and Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis 155
Non-alcoholic fatty liver disease is independently associated with left ventricular hypertrophy in hypertensive type 2 diabetic individuals. 154
Inappropriate left ventricular mass independently predicts cardiovascular mortality in patients with type 2 diabetes. 154
Nonalcoholic fatty liver disease is independently associated with an increased incidence of cardiovascular disease in adult patients with type 1 diabetes 154
Basic knowledge of Medical Statistics is necessary to understand basic medical concepts: some examples. 153
Association between Helicobacter pylori infection and risk of nonalcoholic fatty liver disease: An updated meta-analysis 153
Is fasting glucose variability a risk factor for retinopathy in people with type 2 diabetes? 152
Relation between palmitic acid concentration in the erythrocyte membranes and insulin binding 151
Triglyceride-high-density lipoprotein cholesterol is associated with microvascular complications in type 2 diabetes mellitus. 149
Alterazioni metaboliche e neoplasie. 147
Early impairment in left ventricular longitudinal systolic function is associated with an increased risk of incident atrial fibrillation in patients with type 2 diabetes 147
Increase in Circulating Products of Lipid Peroxidation in Smokers with IDDM. Diabetes Care 19: 1233-1236, 1996 146
Self-reported exercise and quality of life in young type 1 diabetic subjects. 146
Nonalcoholic fatty liver disease in patients with chronic plaque psoriasis. 146
Increased plasma markers of inflammation and endothelial dysfunction and their association with microvascular complications in type 1 diabetic patients without clinically manifest macroangiopathy. 145
Mononuclear leukocytes from obese patients with type II diabetes have reduced activity of hexokinase, 6-phosphofructokinase, and glucose-6-phosphate dehydrogenase. 145
Elevated plasma levels of soluble receptors of tumor necrosis factor-alpha and their association with smoking and microvascular complications in young adults with type 1 diabetes. 145
Relationship between red blood cell distribution width and kidney function tests in a large cohort of unselected outpatients. 144
Body mass index and the risk of mortality in type 2 diabetic patients from Verona 144
Nonalcoholic Fatty Liver Disease Increases Risk of Incident Chronic Kidney Disease: a Systematic Review and Meta-Analysis 144
Steatosi epatica non alcolica in pazienti con psoriasi cronica in placche. 142
The E/e' ratio difference between subjects with type 2 diabetes and controls. A meta-analysis of clinical studies 141
The Verona Diabetes Study: a population-based survey on known diabetes mellitus prevalence and 5-year all-cause mortality 140
Plasma concentrations of glucagon during hyperglycemic clamp with or without somatostatin infusion in obese subjects 138
Studio della prevalenza del diabete mellito a Verona. Confronto ed integrazione fra diverse metodologie di indagine. 136
Associations between liver histology and cortisol secretion in subjects with nonalcoholic fatty liver disease. 135
The aspartate aminotransferase-to-alanine aminotransferase ratio predicts all-cause and cardiovascular mortality in patients with type 2 diabetes 135
Relationship between soluble CD40 ligand and gamma-glutamyltransferase concentrations in non-drinking, young type 1 diabetic individuals 134
Totale 18.991
Categoria #
all - tutte 104.920
article - articoli 96.782
book - libri 0
conference - conferenze 2.428
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 5.710
Totale 209.840


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.463 0 408 49 101 44 87 9 95 62 33 139 436
2022/20233.189 244 289 346 557 281 741 37 201 352 20 82 39
2023/20241.473 62 125 124 191 160 192 59 90 15 145 241 69
2024/20254.023 234 295 185 681 211 137 197 201 597 238 319 728
2025/202611.356 835 704 945 1.714 2.707 827 972 636 817 636 215 348
2026/2027473 162 311 0 0 0 0 0 0 0 0 0 0
Totale 31.456